1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Lung Transplant: new trials by email Literature Review of Lung Transplant trials Research Report on Lung Transplant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection | Early Phase 1 | Terminated | Thunder Bay Regional Health Research Institute | 10 | 2020-11-10 | 2024-10-15 |
| Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System Regadenoson, Placebo - Lung Transplant | Early Phase 1 | Completed | University of Maryland, Baltimore | 47 | 2020-06-22 | 2024-08-05 |
Asbestosis (1) · Asthma (1) · Bronchiectasis (1) · Cystic Fibrosis (1) · Emphysema (1) · Hypertension, Pulmonary (1) · Lung Diseases, Interstitial (1) · Lung Neoplasms (1) · Mesothelioma (1) · Pulmonary Disease, Chronic Obstructive (1) · Pulmonary Embolism (1) · Pulmonary Fibrosis (1) · Rhinitis, Allergic, Seasonal (1) · Sleep Apnea, Obstructive (1)
Adenoma (1) · Apnea (1) · Bronchial Diseases (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Disease Attributes (1) · Dyssomnias (1) · Embolism (1) · Embolism and Thrombosis (1) · Fibrosis (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1)
Sulfur Hexafluoride (1) · perflutren (1) · regadenoson (1)
Thunder Bay Regional Health Research Institute (1) · University of Maryland, Baltimore (1)
Canada (1) · United States (1)
Christine Lau, MD (1) · Mitchell S Albert, PhD (1)
R01HL128492 (1)